Clinical Trial Update: TC or BEP in Treating Patients With Malignant Ovarian Germ Cell Tumors [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating TC or BEP chemotherapy in patients with malignant ovarian germ cell tumors is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer
• Ovarian Germ Cell Tumor
• Ovarian Neoplasms

Snippet

Sponsor: Beihua Kong | Conditions: Ovarian Germ Cell Cancer, Ovarian Neoplasms | Phase 3 | Status: RECRUITING